Concord Medical Services (C2C) Price & Analysis

Concord Medical Services Holdings Limited, together with its subsidiaries, operates an extensive network of specialized radiotherapy and diagnostic imaging facilities across the People's Republic of China. The company's business activities are structured into two primary divisions: Network and Hospital. Its comprehensive service portfolio includes advanced radiation treatments such as external beam radiotherapy, which utilizes linear accelerators, and precise gamma knife radiosurgery systems designed for both cranial and bodily applications. Additionally, the company provides various diagnostic imaging services, incorporating technologies like computed tomography (CT) scanners. Beyond direct medical treatments, Concord Medical offers essential clinical support services. These encompass assisting healthcare professionals in developing effective treatment protocols, coordinating joint diagnoses among its network doctors, and conducting clinical research. The company also plays a role in human resources, specifically in the recruitment and compensation of its medical and support staff. Furthermore, Concord Medical broadens its services to include the leasing of radiotherapy and diagnostic equipment, providing management expertise, and delivering premium cancer and proton treatment services to other hospitals. Its offerings also extend to teleconsultation, medical information technology solutions, and the sale of medical devices. The company also directly manages and operates specialty cancer hospitals that offer a full range of services, including radiotherapy, diagnostic imaging, chemotherapy, and surgical procedures. As of December 31, 2021, Concord Medical's operational footprint consisted of 16 collaborative centers located within 13 different hospitals. Concord Medical Services Holdings Limited was founded in 1997 and has its corporate headquarters in Beijing, People's Republic of China.